Table 4 |
||||
|
Association of health-related quality of life score decrease with comorbidities (mean ± standard deviation; only significant differences of at least 5 points presented) |
||||
|
comorbidity (n = 328/178*) |
coronary heart disease (n = 119/63*) |
diabetes (n = 62/37*) |
COPD (n = 49/29*) |
|
|
|
||||
|
urinary function |
- |
- |
- |
- |
|
|
||||
|
continence function |
5 ± 2 |
6 ± 2 |
7 ± 3 |
- |
|
|
||||
|
irritative/obstructive function |
- |
- |
- |
- |
|
|
||||
|
urinary bother |
6 ± 2† |
7 ± 2† |
9 ± 3† |
- |
|
|
||||
|
continence bother |
- |
- |
- |
- |
|
|
||||
|
irritative/obstructive bother |
5 ± 2† |
6 ± 2† |
8 ± 3† |
- |
|
|
||||
|
sexual function |
9 ± 3† |
- |
16 ± 4† |
- |
|
|
||||
|
sexual bother |
10 ± 4 |
- |
18 ± 6† |
- |
|
|
||||
|
hormonal function |
5 ± 2† |
7 ± 2† |
- |
5 ± 3† |
|
|
||||
|
hormonal bother |
5 ± 2† |
6 ± 2† |
- |
5 ± 3† |
|
|
||||
|
COPD: chronic obstructive pulmonary disease *patients without a prior hormonal therapy (analysis of sexual and hormonal domains) † p < 0.01 |
||||
|
Pinkawa et al. BMC Cancer 2009 9:296 doi:10.1186/1471-2407-9-296 |
||||